| Dr Jiselle Alvarez-granados, OD | |
|
7050 Mall Walk, Yonkers, NY 10704 | |
| (914) 968-2626 | |
| Not Available |
| Full Name | Dr Jiselle Alvarez-granados |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 7050 Mall Walk, Yonkers, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275203093 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 009453 (New York) | Primary |
| Provider Name | Cross County Vision Corp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043806359 PECOS PAC ID: 0143619056 Enrollment ID: O20211116000113 |
News Archive
Black children are less likely than white children to receive medication for abdominal pain in the emergency department (ED) even when they report severe pain, according to a study to be presented Saturday, April 28, at the Pediatric Academic Societies (PAS) annual meeting in Boston.
This week's New England Journal of Medicine features perspectives from prominent authors on Medicare and Medicaid. NEJM granted KHN permission to excerpt substantial portions of these columns.
Anapol Schwartz attorneys Lawrence Cohan and Melissa Fry Hague recently filed two Gardasil vaccine complaints – one on behalf of a Kensington, Calif., family, whose 15-year old daughter died after suffering from severe adverse reactions, and another on behalf of a 19-year old Lapeer, Mich., woman, who has a chronic, autoimmune disorder. The cases, filed in The Court of Federal Claims in Washington, D.C., seek recovery under the National Vaccine Injury Compensation Program.
CNSBio Inc. will present recent Phase IIa proof-of-concept clinical trial data for CNSB015, an orally administered potassium channel modulator used in combination with opioids for the treatment of neuropathic pain, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain on November 20-21, 2009 in San Francisco, CA.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jiselle Alvarez-granados, OD 7050 Mall Walk, Yonkers, NY 10704 Ph: (914) 968-2626 | Dr Jiselle Alvarez-granados, OD 7050 Mall Walk, Yonkers, NY 10704 Ph: (914) 968-2626 |
News Archive
Black children are less likely than white children to receive medication for abdominal pain in the emergency department (ED) even when they report severe pain, according to a study to be presented Saturday, April 28, at the Pediatric Academic Societies (PAS) annual meeting in Boston.
This week's New England Journal of Medicine features perspectives from prominent authors on Medicare and Medicaid. NEJM granted KHN permission to excerpt substantial portions of these columns.
Anapol Schwartz attorneys Lawrence Cohan and Melissa Fry Hague recently filed two Gardasil vaccine complaints – one on behalf of a Kensington, Calif., family, whose 15-year old daughter died after suffering from severe adverse reactions, and another on behalf of a 19-year old Lapeer, Mich., woman, who has a chronic, autoimmune disorder. The cases, filed in The Court of Federal Claims in Washington, D.C., seek recovery under the National Vaccine Injury Compensation Program.
CNSBio Inc. will present recent Phase IIa proof-of-concept clinical trial data for CNSB015, an orally administered potassium channel modulator used in combination with opioids for the treatment of neuropathic pain, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain on November 20-21, 2009 in San Francisco, CA.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
› Verified 3 days ago
Dr. Amy Mundanchira, OD Optometrist Medicare: Medicare Enrolled Practice Location: 598 Tuckahoe Rd, Yonkers, NY 10710 Phone: 914-337-7775 Fax: 718-504-4960 | |
Dr. Reesa Smart, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1070 Mall Walk, Yonkers, NY 10704 Phone: 914-968-2626 | |
Nisim Pilosov, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 598 Tuckahoe Rd, Yonkers, NY 10710 Phone: 914-603-7423 | |
Cohen's Fashion Optical Optometrist Medicare: Medicare Enrolled Practice Location: 7050 Mall Walk, Yonkers, NY 10704 Phone: 914-881-3749 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1765 Central Park Ave, Yonkers, NY 10710 Phone: 914-961-1004 Fax: 914-961-7636 | |
Dr. Marc Wayne Greenberg, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 770 Mclean Ave, Yonkers, NY 10704 Phone: 914-803-0500 | |
Fariha Fatima Sabiri, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2349 Central Park Ave, Yonkers, NY 10710 Phone: 224-633-8333 |